<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18-viruses-09-00147">
 <label>18.</label>
 <element-citation publication-type="confproc">
  <person-group person-group-type="author">
   <name>
    <surname>Grimley</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Papanicolaou</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Maron</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Chittick</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Brundage</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Bae</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Mommej-Marin</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Nichols</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Prasad</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>In Improved outcomes in allogeneic hematopoietic cell transplant (allo hct) patients treated with brincidofovir for disseminated adenovirus (AdV) disease compared to literature: Updated preliminary results from the advise (cmx001-304) study</article-title>
  <source>Proceedings of the 41st Annual Meeting of the European Society for Blood and Marrow Transplantation</source>
  <conf-loc>Istanbul, Turkey</conf-loc>
  <conf-date>22â€“25 March 2015</conf-date>
 </element-citation>
</ref>
